Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
"Dual GIP and GLP-1 Receptor Agonist Tirzepatide Improves Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes." J Clin Endocrinol Metab
You might find yourself thinking about food more, feeling less satisfied after meals, or noticing that the "I could eat" feeling returns
Clinicians are satisfied
Its unique multi-pathway profile makes it a compound of interest in advanced research settings
In a mid-stage clinical trial, the highest weekly injection dose produced about 24% average weight loss at 36 weeks, and the highest oral dose produced about 13% weight loss over 12 weeks
US$ 20.37
US$ 21.80
US$ 22.75
US$ 24.38
US$ 28.49
US$ 26.81
US$ 28.18
US$ 29.39
US$ 26.46
